ATLANTA, June 12, 2013 /PRNewswire-iReach/ -- Dr. M. Fatih Yanik has recently joined the team at Intellimedix and will oversee the company's new technology development efforts. Dr. Yanik is an associate professor in the Electrical Engineering department of MIT and heads the school's High-Throughput Neurotechnology Group. In 2011, he was awarded the most prestigious NIH award, the NIH Director's Pioneer Award, and is the youngest recipient in the history of this award. Dr. Yanik is also the first person ever to receive all of the top NIH awards: the NIH Director's New Innovator Award, the NIH EUREKA Award, the NIH Transformative Research Award, and the NIH Director's Pioneer Award.
"Fatih Yanik is a pioneer in the development of technologies for regenerative neurobiology and development of innovative drug discovery models and platforms. Additionally, Dr. Yanik and his research team have developed a novel and groundbreaking method of creating induced pluripotent stem cells (iPSCs) using RNA-based technology that holds great promise for personalized neurobiology. Fatih brings a treasure trove of talent to Intellimedix," says Dr. Jeffrey Skolnick, Chief Scientist at Intellimedix.
"Intellimedix has a very dedicated and world-class team who is truly passionate about finding cures for epilepsy and other neurological disorders. I am truly excited to join them in this endeavor as we set out to improve the quality of life for many people," says Dr. Yanik.
Dr. Yanik will play a major role in developing novel technologies and guiding the research at Intellimedix's Cambridge, MA based lab.
IntelliMedix was founded in early 2012 with the purpose of developing and applying novel technologies to accelerate the discovery of new therapies for neurological diseases and creating new approaches for personalized medicine. They employ cutting-edge technology that includes gene sequencing, in silico screening, optogenetics, synthetic biology, and high-throughput in vivo and in vitro models. The company's current focus is on developing new treatments for Dravet Syndrome and other types of intractable epilepsy. For more information, please visit http://www.intellimedix.com
Joanna Morrison Intellimedix, 770.399.9930, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
Copyright©2012 PR Newswire.
All rights reserved